OR WAIT null SECS
© 2023 MJH Life Sciences and BioPharm International. All rights reserved.
© 2023 MJH Life Sciences™ and BioPharm International. All rights reserved.
November 16, 2023
Lonza’s new GS Effex cell line can help overcome the challenges of developing therapeutic antibodies with increased potency.
November 06, 2023
CDMOs are actively exploring and leveraging both new and existing technologies to streamline the cell-line development process at every step.
October 10, 2022
Cytiva’s acquisition of CEVEC Pharmaceuticals strengthens the company’s cell line development and biomanufacturing capabilities.
July 02, 2022
Industry adoption of plant-made biologics remains slow, but plant-based technology gains an advantage by mainstream exposure.
March 02, 2022
The use of bioengineering offers practical tools for the evolution of host cells.
July 22, 2021
Catalent Biologics has launched its new cell line expression technology, GPEx Lightning, which aims to shorten drug substance development timelines by up to three months.
April 06, 2021
The company has introduced Opto Assure, a series of assays that provide yield and product quality data at an earlier stage in cell-line development.
January 02, 2021
Cell-culture optimization may see benefits from a synthetic biology-based approach that improves product titer, quality, and time.
October 29, 2020
Samsung Biologics has adopted Solentim’s cell seeding and cell metric platforms at its new R&D center in San Francisco, CA.
Mogrify’s new technology platform, EpiMOGRIFY, can predict cellular switches important for determining cell identity, cell maintenance, directed differentiation, and cell conversion.